Document is current

Article History

First Online: 12 May 2018

Compliance with Ethical Standards

:

: No funding was provided.

: Sophie Berends has received lecture fees from Merck Sharp & Dohme, Johnson & Johnson and Tillotts. Anne Strik has received lecture fees from Biogen, Johnson and Johnson, Merck Sharp & Dohme, Mundipharma, Takeda, and Tillotts. Mark Löwenberg has received speaker fees from Abbvie, Covidien, Dr. Falk Pharma, Ferring Pharmaceuticals, Merck Sharp & Dohme, Receptos, Takeda, Tillotts and Tramedico, and has also received research grants from AbbVie, Merck Sharp & Dohme, Achmea Healthcare and ZonMW. Geert D’Haens has served as an advisor for Abbvie, Ablynx, Amakem, AM Pharma, Avax- ia, Biogen, Bristol-Myers Squibb, Boerhinger Ingelheim, Celgene, Celltrion, Cosmo, Covidien, Ferring, Dr. Falk Pharma, Engene, Galapagos, Gilead, GlaxoSmithKline, Hospira, Immunic, Johnson and Johnson, Lycera, Medimetrics, Millenium/Takeda, Mitsubishi Pharma, Merck Sharp & Dohme, Mundipharma, Novonordisk, Pfizer, Prometheus Laboratories/Nestle, Protagonist, Receptos, Robarts Clinical Trials, Salix, Sandoz, Setpoint, Shire, Teva, Tigenix, Tillotts, Topivert, Versant and Vifor, and has also received speaker fees from Abbvie, Ferring, Johnson and Johnson, Merck Sharp & Dohme, Mundipharma, Norgine, Pfizer, Shire, Millenium/Takeda, Tillotts and Vifor. Ron Mathôt has no conflicts of interest to declare.